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Young male rats were used to investigate the effect 
of zinc toxicity on the metabolism of calcium, phosphorus, 
magnesium, zinc, copper, and iron in the presence and the 
absence of calcium and phosphorus supplements. 
Results of the study indicated that calcium and phos- 
phorus supplementation prevents the marked decreases in the 
retention of calcium and phosphorus in young rats associated 
with zinc toxicity.  The data suggest that calcium and phos- 
phorus supplements furnish sufficient amounts of these 
minerals to replace the amounts lost by the adverse action 
of zinc and facilitate the removal of some of the excess 
zinc from the animal body. 
The addition of calcium, phosphorus, or zinc supple- 
ments to diets of young rats resulted in decreases in the 
percentage of the total magnesium intake that was retained. 
Zinc toxicity was associated with a marked increase 
in the apparent absorption and retention of zinc.  Calcium 
and phosphorus supplements added to the high zinc diet 
resulted in additional increases in zinc retention. 
Animals receiving diets without added zinc were in negative 
zinc balances. 
Zinc toxicity resulted in a marked increase in the 
apparent absorption and retention of copper. In general, 
the addition of calcium or phosphorus to the high zinc diet 
resulted in additional improvements in copper retention. 
Calcium and phosphorus supplements partially 
alleviated the adverse effect of zinc toxicity on weight 
gain, hemoglobin level, and liver copper accumulation. 
Supplements of these two minerals also prevented the marked 
increase in liver zinc deposition associated with zinc 
toxicity. 
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CHAPTER I 
INTRODUCTION 
In the normal animal delicate balances often exist 
between various essential nutrients which can be upset if 
one or more of the nutrients involved in a specific inter- 
relationship is present in the diet in abnormal concentra- 
tions.  The physiological behavior of animals consuming 
ingredients not generally considered dietary essentials 
has stimulated research in many areas of nutrition, partic- 
ularly in the area of trace mineral excesses.  Of great 
interest has been the biological response of animals to 
diets containing high levels of zinc. 
Zinc toxicosis is associated with several adverse 
conditions in the animal, such as depression in weight gain, 
interference with bone mineralization, and interference 
with the metabolic pathways of calcium, copper, iron, mag- 
nesium, and phosphorus.  Although many of the symptoms of 
the zinc toxicity syndrome have been characterized, the 
sites and the modes of interference of zinc with the 
various metabolic processes involved remain enigmas. 
A recent report has shown that calcium and phos- 
phorus supplements will alleviate the adverse effects of 
zinc on the weight gains and on the deposition of calcium 
and phosphorus in the bones of young rats.  The mechanism(s) 
involved, however, have not been determined.  Furthermore, 
there is the possibility that the interrelationships between 
zinc and other elements, other than calcium and phosphorus, 
which exist in the animal body may be influenced by calcium 
and phosphorus supplementation.  The present investigation 
was directed towards the elucidation of some of these prob- 
lems because it might serve as the means of obtaining 
additional information pertaining to the roles of certain 
mineral nutrients in the animal body. 
CHAPTER II 
REVIEW OF LITERATURE 
Sutton and Nelson (1, 2) reported that high levels of 
dietary zinc had adverse effects on the growth, hemoglobin 
levels, and reproductive capabilities of rats in 1937, but 
almost a decade passed before additional research was con- 
ducted to characterize the zinc toxicity syndrome.  In 1946 
Smith and Larson (3) reported that the etiologies of the 
subnormal growth and the anemia associated with zinc toxi- 
cosis were separate and distinct-  Subsequent experimenta- 
tion revealed that high levels of dietary zinc resulted in 
lowered catalase, cytochrome oxidase, and xanthine oxidase 
activities (4, 5, 6, 7), decreases in tissue copper and iron 
levels (8, 9, 10), increases in liver zinc levels (10, 11), 
and interfered with the normal metabolism of calcium and 
phosphorus (12, 13, 14). 
Although the exact mechanism(s) involving the inter- 
ference of zinc with growth has not been determined, results 
of several studies indicated that dietary supplements of 
liver and distillers dried solubles can alleviate the effect 
of zinc toxicity on weight gain (3, 10, 15).  Magee and 
Matrone (10) reported that the factor(s) of liver extract 
that alleviated subnormal growth appeared to reside in the 
organic portion of the extract.  McCall e_t al. (16) reported 
that the severity of zinc toxicity on growth depended upon 
the source and the level of dietary protein.  Magee and 
Spahr (15), however, found that high levels of dietary pro- 
tein accentuated, rather than reduced, the severity of zinc 
toxicity, and their data indicated that dietary protein per 
se was not the primary factor involved in the growth depres- 
sion.  Recently, Stewart and Magee (17) have reported that 
dietary supplements of calcium and phosphorus will partially 
alleviate the depression in weight gains of young rats fed 
high levels of zinc. 
Van Reen (4) observed beneficial effects of copper 
supplements on the depressed activities of liver catalase 
and cytochrome oxidase.  Depression in heart cytochrome 
oxidase activity could also be prevented with supplements of 
copper (5, 10).  Copper supplementation prevented the marked 
decreases in tissue copper levels, but iron supplementation 
did not prevent the decreases in tissue iron levels associ- 
ated with zinc toxicity (10) .  Magee and Spahr (15) reported 
that a 20% level of distillers dried solubles added to a 
high zinc diet significantly reduced liver zinc accumulation. 
Sadasivan (12) observed that high levels of zinc were 
associated with marked decreases in bone calcium and phos- 
phorus levels in rats.  Other reports indicate that zinc 
toxicosis results in decreases in the retentions of calcium, 
phosphorus, and magnesium in rats (13, 14, 17) and decreases 
in the retentions of calcium and phosphorus in lambs (18). 
Stewart and Magee (17) found that calcium and phos- 
phorus supplements alleviated the antagonistic effect of 
zinc on the normal deposition of calcium and phosphorus in 
the bones of young rats.  Although the results of their 
study indicated that the calcium and phosphorus supplements 
facilitate the removal of excess zinc from the animal body 
so that near normal conditions exist with respect to zinc 
absorption and utilization, the exact mechanism(s) involved 
remains an enigma.  There is the possibility that a study 
of the effects of calcium and phosphorus on the retentions 
of these minerals by zinc-fed rats may yield additional 
information concerning the calcium-phosphorus-zinc inter- 
relationship.  If the primary action of calcium and phos- 
phorus supplements is to facilitate the removal of zinc, 
there is the possibility that these supplements could 
alleviate the adverse effect of zinc on copper and iron 
metabolism. 
CHAPTER III 
EXPERIMENTAL PROCEDURES 
The primary objectives of this study were to investi- 
gate (a) the nature of the interference of zinc with calcium, 
phosphorus, and magnesium metabolism and (b) the effects of 
calcium and phosphorus supplements on the metabolism of 
copper, iron, and zinc in zinc-fed rats. 
The study was divided into two parts.  Part I pertains 
to a metabolism experiment designed to show the effect of 
zinc toxicity on the retentions of calcium, phosphorus, 
magnesium, copper, and zinc in young rats in the presence 
and absence of calcium and phosphorus supplements.  In 
part II the effects of calcium and phosphorus supplements 
on weight gains, hemoglobin levels, and the deposition of 
copper, iron, and zinc in the livers of rats fed high levels 
of zinc were studied. 
Young male albino rats1 were used for all phases of 
the study.  The animals were housed in individual wire- 
bottom metabolism cages which were fixed so that feces and 
urine could be collected separately.  Fresh feed was 
iSprague-Dawley rats purchased from Holtzman Company 
Madison, Wisconsin. 
provided daily, and food consumption records for each animal 
were kept.  The animals had free access to distilled water 
at all times.  The animals used in the study were randomized 
into replications according to initial body weights.  Experi- 
mental diets and animals within a replication were assigned 
at random to individual cages. 
A 23 factorial design was utilized and included two 
levels of zinc, calcium, and phosphorus.  The dietary supple- 
ments were fed alone and in combination to furnish, in 
addition to the control, the following experimental diets: 
0.8% calcium, 0.8% phosphorus, 0.8% calcium +0.8% phos- 
phorus, 0.75% zinc, 0.75% zinc +0.8% calcium, 0.75% zinc + 
0.8% phosphorus, and 0.75% zinc +0.8% calcium +0.8% phos- 
phorus . 
The composition of the basal diet used in the study 
is given in Table 1.  Chemical analyses of representative 
samples of this basal showed that it contained an average 
of 0.51% of calcium, 0.55% of phosphorus, 0.05% of magnesium, 
5 ppm. of copper, and 3 ppm. of zinc.  Supplements were 
incorporated into the basal at the expense of equal amounts 
of starch.  Zinc was fed as the carbonate; supplements of 
calcium and phosphorus were in the carbonate and potassium 
dihydrogen phosphate forms, respectively. 
Mineral Balance Study 
Thirty-two animals, averaging 53 grams in weight 
initially, were divided equally into eight groups.  Each 
TABLE 1 
COMPOSITION OF THE BASAL DIET 
8 
Constituents 
Casein3 
Corn  starch*3 
Vegetable   fatc 
Mineral  mixd 
Vitamin  mixe 
Cellulosef 
Oleum percomorphum9 
Per cent 
19 
63 
10 
4 
2 
2 
aVitamin Test Casein, Nutritional Biochemi- 
cals Corporation, Cleveland, Ohio. 
bGlobe Easy-flow Corn Starch 3367, Corn Prod- 
ucts Sales Company, Greensboro, North Carolina. 
cCrisco, Procter and Gamble Company, Cincinnati, 
Ohio. 
Salt Mixture W, Nutritional Biochemicals 
Corporation, Cleveland, Ohio.  The composition of this 
salt mixture is listed as:  (in per cent) CaC03, 21.000; 
CUSO4.5H-O, 0.039; FePO4-2H20, 1.470; MnS04, 0.020; 
MgS04, 97000; KA1 (SO4)2•12fl20, 0.009; KC1, 12.000; 
KH2PO4 31.000; KI, 0.005; NaCl, 10.500; NaF, 0.057; 
and Ca3(P04)2, 14.900. 
eEach 100 gm. of vitamin mix contained:  (in 
milligrams) 0.1% vitamin B12 (with mannitol), 0.1; 
biotin, 1; folic acid, 5; thiamine-HCl, 25; pyridoxine- 
HC1, 25; 2-methyl-naphthoquinone, 50; riboflavin, 50; 
nicotinic acid, 50; Ca pantothenate, 150; p-amino- 
benzoic acid, 500; (in grams) inositol 5; choline 
chloride, 7.5; DL-methionine, 30; and corn starch, 
56.6.  All vitamins and methionine were purchased 
from Nutritional Biochemicals Corporation, Cleveland, 
Ohio. 
fAlphacel, Nutritional Biochemicals Corporation, 
Cleveland, Ohio. 
9"Each kilogram of diet contained 24 drops of 
oleum percomorphum, Mead Johnson and Company, Evans- 
ville, Indiana. 
group received one of the experimental diets previously 
mentioned. 
The experimental period covered a total of four weeks, 
and during this time one collection period was utilized. 
The collection period was conducted during the last week the 
animals were on the dietary regimens.  Respective excreta 
from an individual animal were collected daily, pooled, and 
kept in sealed containers in a refrigerator until they could 
be analyzed.  Samples of the pooled fecal and urine collec- 
tions from each animal for the repsective collection period 
were prepared for mineral analyses by ashing with nitric and 
perchloric acids on a hot plate.  The ash of each sample was 
dissolved in 3 ml. of 0.6N HC1 and brought to a volume of 
100 ml. with redistilled water.  Representative samples of 
the eight experimental diets were also prepared for mineral 
analyses by the same procedures.  Calcium, phosphorus, 
magnesium, copper, and zinc determinations were made on 
appropriate aliquots of the feed, fecal, and urine samples 
by the methods of Weybrew et al. (19), Simonsen et a^. (20), 
Simonsen et al. (21), Parks et_ al. (22) as modified by 
Matrone et al. (23), and McCall et. al- (24), respectively. 
Growth, Hemoglobin, and Liver Mineral Study 
Sixty-four animals were utilized for this phase of 
the investigation and were divided equally into eight groups. 
Each group received one of the experimental diets previously 
mentioned.  The animals were kept on their respective 
10 
dietary regimens for four weeks.  At the end of the experi- 
mental period, blood samples were taken from the tails of 
each animal.  Hemoglobin determinations, by the method of 
Shenk et al. (25), were made on the blood samples.  All 
animals were killed, and the liver of each was removed and 
weighed.  A small portion of each liver was dried separately 
at 35°C in order to provide dry weight data.  The remainder 
of each liver was prepared for mineral analyses by the wet- 
ashing procedure previously mentioned.  The ash of each 
liver sample was dissolved in 0.6N HC1 and brought to a 
volume of 25 ml. with redistilled water.  Copper and zinc 
determinations were made on appropriate aliquots of the 
liver samples by the methods previously mentioned.  Iron 
determinations were made on the samples using the method of 
Kitzes et al. (26), as modified by Matrone et al. (23). 
CHAPTER IV 
RESULTS AND DISCUSSION 
Mineral Balance Study 
Detailed data gathered during this phase of the 
investigation are presented in Appendix A, Tables 1-6. 
Calcium 
Zinc toxicity resulted in a highly significant 
decrease (p^O.Ol) in the retention of calcium by young 
rats which could be prevented by supplementing the diet 
with calcium (Table 2).  In the absence of zinc, phosphorus 
supplementation resulted in an increase in calcium retention, 
but when phosphorus was added to a high zinc diet, a nega- 
tive calcium balance resulted in the animals.  Supplements 
of calcium, in the absence of zinc, resulted in marked 
improvements in calcium retention.  The greatest amount of 
calcium retention occurred in animals fed the basal diet 
supplemented with calcium and phosphorus. 
The data indicated that zinc results in a significant 
increase in the fecal excretion of calcium and a corres- 
ponding decrease in the apparent absorption of calcium.  The 
addition of calcium to the high zinc diet furnished suffi- 
cient amounts of this mineral to replace that lost by the 
TABLE 2 
CALCIUM BALANCE SUMMARYC 
Ca Intake 
(mg./day) 
Ca Excr 
Feces 
(mg. 
eted in 
Urine 
/day) 
Ca Absorbed Ca Retention 
Diet (mg./day) (%) (mg./day) (%) 
Basal 66.93 38.99 0.51 27.94 41.7 27.43 40.9 
Basal + 0.8% Ca 288.11 141.49 1.15 146.62 50.8 145.70 50.5 
Basal + 0.8% P 82.05 35.40 1.61 46.65 56.8 45.04 54.9 
Basal + 0.8% Ca 
+ 0.8% P 292.14 89.61 2.04 202.53 69.3 200.49 68.6 
Basal + 0.75% Zn 61.38 55.25 0.78 6.13 10.0 5.35 8.7 
Basal + 0.75% Zn 
+ 0.8% Ca 208.13 123.19 0.43 84.94 40.8 84.51 40.6 
Basal + 0.75% Zn 
+ 0.8% P 79.38 88.59 2.05 - 9.21b — -11.26b — 
Basal + 0.75% Zn 
+ 0.8% Ca + 0.8% P 232.59 131.21 1.16 101.38 43.5 100.22 43.1 
Each figure is the mean of 4 animals. 
bA negative percentage value would result from the negative number.  Such a 
value is meaningless; therefore, it has not been calculated. to 
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adverse effect of zinc on calcium metabolism.  In the absence 
of zinc, phosphorus had no marked influence on fecal calcium, 
but when phosphorus was added to the high zinc diet, a marked 
increase in fecal calcium excretion resulted.  Calcium sup- 
plements, in the absence of zinc, resulted in a marked 
improvement in the apparent absorption of calcium. 
Zinc caused a slight increase in the urinary excretion 
of calcium, but the presence of phosphorus supplements was 
associated with marked increases in urinary calcium.  Rats 
receiving only calcium supplements had increased urinary 
calcium levels.  Supplements of calcium, however, prevented 
the adverse effect of zinc on urinary calcium excretion. 
Phosphorus 
The presence of calcium, phosphorus, and zinc supple- 
ments in the diets of young rats was associated with marked 
decreases in the percentage of the phosphorus intake retained 
by the animals (Table 3).  The data indicated that 0.75% 
zinc had the greatest adverse effect on phosphorus retention. 
Phosphorus supplementation was associated with marked im- 
provements in the amounts of phosphorus retained even though 
the percentage phosphorus retention was lower than that 
observed in the control animals.  The data also indicate 
that calcium supplements resulted in slightly better per- 
centage phosphorus retention than did phosphorus supplements. 
In this study the addition of calcium, phosphorus, 
and zinc to the diet was associated with increases in fecal 
TABLE 3 
PHOSPHORUS BALANCE SUMMARY a 
P Intake P Excreted in P Absorbed P Retention 
(mg./day) 
Feces  Urine 
(mg./day) Diet (mg./day) (%) (mg./day) {%) 
Basal 71.37 14.02 21.45 57.35 80.3 35.90 50.3 
Basal + 0.8% Ca 75.15 43.09 2.77 32.06 42.6 29.29 38.9 
Basal + 0.8% P 176.42 22.06 96.52 154.36 87.4 57.84 32.7 
Basal + 0.8% Ca 
+ 0.8% P 190.77 51.38 73.64 139.39 73.0 65.75 34.4 
Basal + 0.75% Zn 61.18 32.80 16.61 28.38 46.3 11.77 19.2 
Basal + 0.75% Zn 
+ 0.8% Ca 74.59 44.95 9.91 29.64 39.7 19.73 26.4 
Basal + 0.75% Zn 
+ 0.8% P 164.36 47.48 85.49 116.88 71.1 31.39 19.1 
Basal + 0.75% Zn 
+ 0.8% Ca + 0.8% P 187.79 72.85 61.23 114.94 61.2 53.71 28.6 
aEach figure is the mean of 4 animals. 
H 
4* 
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phosphorus levels.  Calcium and zinc supplements, alone and 
in combination, were associated with decreases in the 
amounts of phosphorus excreted in the urine.  Supplements 
of phosphorus were associated with highly significant 
increases (pjS^O.Ol) in urinary phosphorus.  Although there 
was a marked increase in the amount of phosphorus intake in 
rats fed diets containing the phosphorus supplement, the 
marked increase in urinary phosphorus in rats receiving 
these diets was sufficient to result in a lower percentage 
of phosphorus retention. 
Magnesium 
The main effects of phosphorus and zinc were to de- 
crease the amount of magnesium retained, while the main 
effect of calcium was to increase the amount of magnesium 
retained (Table 4).  However, the percentage of the total 
magnesium intake retained was less in the animals supple- 
mented with calcium, phosphorus, and zinc than in the ani- 
mals receiving only the basal.  Although calcium and zinc 
supplements added separately to the basal resulted in de- 
creases in magnesium retention, the combination of both 
supplements was associated with an increase in the amount 
of magnesium retained by the animal.  The presence of added 
dietary phosphorus was associated with decreases in the 
amounts of magnesium retained in all cases. 
The addition of high levels of calcium, phosphorus, 
or zinc resulted in increases in the amount of magnesium 
TABLE   4 
MAGNESIUM  BALANCE   SUMMARYC 
Diet 
Mg Intake   Mq Excreted in 
Feces    Urine 
(mg. /day)      (mg. /d ay) 
Mg Absorbed     Mg Retention 
(mg./day)  (%)   (mg./day)  (%) 
Basal 
Basal + 0.8% Ca 
Basal + 0.8% P 
Basal + 0.8% Ca 
+ 0.8% P 
Basal + 0.75% Zn 
Basal + 0.75% Zn 
+ 0.8% Ca 
Basal + 0.75% Zn 
+ 0.8% P 
Basal + 0.75% Zn 
+ 0.8% Ca + 0.£ 
6.87 1.96 0.20 
7.37 4.08 0.14 
6.94 3.16 0.21 
8.03 3.66 0.13 
6.20 2.73 0.19 
8.29 
6.53 
8.04 
3.41 
3.79 
4.32 
0.37 
0.18 
0.11 
4.91 71.5 
3.29 44.6 
3.78   54.5 
4.88   58.9 
2.74   42.0 
3.72   46.3 
4.71 68.6 
3.15 42.7 
3.57    51.4 
4.37   54.4     4.24    52.8 
3.47   56.0     3.28    52.9 
4.51    54.4 
2.56    39.2 
3.61    44.9 
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excreted in the feces and corresponding decreases in the 
apparent absorption of magnesium.  The main effect of cal- 
cium was to decrease urinary magnesium, but the main effects 
of phosphorus and zinc were to increase the excretion of 
magnesium in the urine. 
Zinc 
All animals which did not receive a high level of 
zinc were in a negative zinc balance since they were excret- 
ing more zinc than they were receiving from their respective 
diets (Table 5) .  When zinc was added to the diet, a highly 
significant increase (p^O.Ol) in the apparent absorption 
and retention of zinc resulted.  In the absence of zinc, 
calcium and phosphorus supplements were associated with 
slight improvements in the apparent absorption and retention 
of zinc.  When calcium and phosphorus supplements were added 
to the high zinc diet there was an increase in the amount of 
zinc that was absorbed and retained. 
Calcium and phosphorus supplements, in the presence 
of zinc, were associated with substantial increases in the 
fecal excretion of zinc.  Although increases in the amount 
of zinc in the urine occurred in animals receiving each 
dietary supplement, the results indicated that zinc and cal- 
cium had a greater effect on urinary zinc than did phosphorus, 
Copper 
Although all animals in this study were in negative 
TABLE 5 
ZINC BALANCE SUMMARY3 
Zn Intake Zn Exc reted in Zn Absorbed Zn Retention 
(mg./day) 
Feces 
(mg. 
Urine 
/day) Diet (mg./day) (%) (mg./day)  (%) 
Basal 0.039 0.710 0.029 - 0.671 _b - 0.700 
Basal + 0.8% Ca 0.113 0.067 0.100 0.460 40.7 - 0.054 
Basal + 0.8% P 0.052 0.266 0.051 - 0.214 - - 0.265 
Basal + 0.8% Ca 
+ 0.8% P 0.058 0.317 0.037 - 0.282 - - 0.296 
Basal + 0.75% Zn 45.423 21.625 0.123 23.798 52.4 23.675  52.1 
Basal + 0.75% Zn 
+ 0.8% Ca 81.707 37.542 0.188 44.165 54.0 43.977  53.8 
Basal + 0.75% Zn 
+ 0.8% P 
Basal + 0.75% Zn 
+ 0.8% Ca + 0.8% P 
62.480    14.100    0.094     48.380   77.4     48.286  77.3 
55.045    18.597    0.066     36.448   66.2     36.382  66.1 
aEach figure is the mean of 4 animals. 
^Negative percentage values are meaningless and have not been calculated. 
s 
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copper balance (Table 6), the results indicate that zinc 
toxicity was associated with a marked increase in copper 
retention.  In the absence of zinc, calcium added to the 
basal had no effect on copper retention, while phosphorus 
supplementation was associated with a decrease in copper 
retention.  In combination, however, these supplements were 
associated with a marked improvement in copper retention. 
In the presence of zinc, calcium and phosphorus added sepa- 
rately to the diet were associated with an additional 
improvement in copper retention.  However, when both supple- 
ments were added in combination to the high zinc diet, the 
improvement in copper retention was not as good as that 
observed when either supplement was added separately to the 
high zinc diet.  These results indicate a significant cal- 
cium x phosphorus interaction with respect to copper 
metabolism. 
Animals receiving the high zinc diets excreted less 
copper in the feces than did those not receiving supple- 
mental levels of zinc, and the data indicated that zinc 
significantly improved the apparent absorption of copper. 
The main effect of calcium and phosphorus supplements was 
to improve the apparent absorption of copper by decreasing 
the fecal excretion of copper.  Calcium and phosphorus 
supplements appeared to have the greatest effect on the 
urinary excretion of copper. 
wmmm 
TABLE   6 
COPPER BALANCE   SUMMARY3 
aEach  figure   is  the  mean  of  4  animals. 
Cu Intake Cu Excreted in Cu Absorbed Cu Retention 
(meg./day) 
Feces 
(meg 
Urine 
./day) Diet (meg./day) (meg./day) 
Basal 76.21 459.23 1.32 -383.02 -384.34 
Basal + 0.8% Ca 70.89 436.59 5.29 -365.70 -370.99 
Basal + 0.8% P 61.21 481.26 6.39 -420.05 -426.44 
Basal + 0.8% Ca 
+ 0.8% P 71.72 283.27 3.31 -211.55 -214.86 
Basal + 0.75% Zn 45.96 88.71 1.54 - 42.75 - 44.29 
Basal + 0.75% Zn 
+ 0.8% Ca 57.20 79.44 2.06 - 22.24 - 24.30 
Basal + 0.75% Zn 
+ 0.8% P 57.43 60.36 0.97 -  2.93 -  3.90 
Basal + 0.75% Zn 
+ 0.8% Ca + 0.8% P 62.74 89.92 3.01 - 27.18 - 30.19 
(O 
■■■■■ 
Growth, Hemoglobin, and Liver Mineral Study 
Detailed data showing the effects of calcium and 
phosphorus supplements on the weight gains, hemoglobin 
levels, and liver mineral deposition in the presence and 
absence of zinc are given in Appendix B, Tables 1-5.  Mean 
values of these criteria are presented in Table 7. 
Growth 
A high level of dietary zinc resulted in a highly 
significant decrease (p^O.Ol) in weight gain which could 
be partially alleviated with supplements of 0.8% calcium or 
0.8% calcium plus 0.8% phosphorus.  Supplements of 0.8% 
phosphorus did not prevent the subnormal growth associated 
with zinc toxicity in this study. 
Hemoglobin 
Analysis of the results indicated that a 0.7 5% level 
of dietary zinc was associated with a highly significant 
decrease (p-^0.01) in hemoglobin level.  Supplements of 
calcium and phosphorus, in the absence of zinc, had no 
apparent effect on hemoglobin level.  In the presence of 
zinc, only a combination of calcium and phosphorus supple- 
ment partially alleviated the adverse effect of zinc on 
hemoglobin levels. 
Liver copper 
The addition of 0.75% zinc to the diets of young 
rats resulted in a highly significant decrease (p^O.01) 
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TABLE   7 
EFFECTS   OF  CALCIUM,    PHOSPHORUS,   AND   ZINC   SUPPLEMENTS 
ON WEIGHT   GAINS,   HEMOGLOBIN LEVELS,   AND 
LIVER  COPPER,   IRON,   AND   ZINC   VALUES3 
Level of 
Zinc (%) 
Levels of Calcium and Phosphorus (%) 
Ca    0      0.8      0       0.8 
P     0        0      0.8      0.8 
0 
0.75 
0 
0.75 
0 
0.75 
0 
0.75 
0 
0.75 
Weight gain at 4 weeks (gm.) 
169      167      164      162 
126      138      125      149 
Hemoglobin (gm./lOO ml blood) 
13.4     12.9     13.4     13.3 
7.0     7.6      7.8     10.8 
Liver copper (mcg./gm. dry weight) 
10.2     12.3     11.4     12.5 
3.6      3.6      2.8      6.3 
Liver iron   (mcg./gm.   dry weight) 
276.1       254.2 270.7 207.5 
113.5        119.6 112.1 150.8 
Liver zinc   (mcg./gm.   dry weight) 
35.3 32.1 42.0 50.7 
349.3        241.8 189.3 89.2 
aEach  figure   is   the  mean  of 8   animals. 
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in liver copper accumulation.  In the absence of zinc, cal- 
cium and phosphorus supplements were associated with increases 
in liver copper deposition.  These increases, however, were 
not statistically significant.  The data also indicated that 
a supplement of 0.8% calcium plus 0.8% phosphorus partially 
prevented the adverse effect of zinc on liver copper. 
Liver iron 
The addition of 0.75% zinc to the diets of young rats 
resulted in a highly significant reduction (p^O.Ol) in 
liver iron level.  Although calcium and phosphorus supple- 
ments, either singly or in combination, did not signifi- 
cantly prevent the marked decrease in liver iron associated 
with zinc toxicity, there was some improvement in liver iron 
when both of these minerals were added to the high zinc diet. 
In the absence of zinc, calcium appeared to have a depressing 
effect on liver iron deposition when it was added to the 
diet.  Phosphorus had no apparent effect on liver iron in 
the presence or absence of zinc when it was the only supple- 
ment added to the basal. 
Liver zinc 
A high level of dietary zinc resulted in an increase 
in liver zinc level which was significant at the 1% level 
of probability.  When supplements of calcium were added to 
the high zinc diet, there was a significant reduction 
(p-^0.05) in liver zinc accumulation.  Supplements of 
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phosphorus resulted in zinc levels which were significantly- 
different from those of the zinc-fed rats at the 1%  level 
of probability.  A combination of calcium and phosphorus 
completely prevented the increase in liver zinc associated 
with zinc toxicosis because the mean zinc level of the 
zinc-fed animals receiving these minerals was not signifi- 
cantly different from the mean zinc level of the animals 
receiving only the basal diet. 
CHAPTER V 
GENERAL DISCUSSION 
Results of this investigation indicate that the an- 
tagonistic effect of zinc on the normal excretion and 
retention of calcium and phosphorus in young rats can be 
alleviated with calcium and phosphorus supplements.  Evalu- 
ation of the data suggests that the beneficial action of 
these supplements is two-fold.  There is evidence that cal- 
cium and phosphorus supplements added to high zinc diets 
furnish sufficient amounts of these minerals to replace the 
amounts lost by the adverse action of zinc.  The results of 
the zinc balance portion of the study showing a marked 
increase in fecal zinc levels in zinc-fed rats supplemented 
with calcium support the proposal of Stewart and Magee (17) 
that this supplement partially alleviated the adverse effect 
of zinc on the animal body by facilitating the removal of 
excess zinc from the system.  The improvement in hemoglobin 
levels, the increase in liver copper and iron deposition, 
and the decrease in liver zinc accumulation in zinc-fed rats 
supplemented with calcium and phosphorus also support the 
thesis that part of the beneficial effect of these supple- 
ments is to remove excess zinc from the body.  If the only 
action of the calcium and phosphorus supplements was to 
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replace those amounts lost by the adverse effect of zinc, 
one could reason that the excess zinc would still be present 
in the animal body and would continue to adversely affect 
copper and iron levels in the liver and hemoglobin concen- 
trations.  The data, however, suggest that both mechanisms 
are probably involved. 
The antagonistic effect of zinc on calcium absorption 
and retention appears to involve a fairly simple mechanism 
in that a level of 0.8% calcium supplement completely 
alleviated the adverse effect of zinc toxicity on calcium 
metabolism.  The adverse effect of zinc toxicity on phos- 
phorus metabolism, however, seems to be more complex since 
a level of 0.8% of phosphorus did not result in an increase 
in phosphorus retention in zinc-fed rats.  Although the 
apparent absorption of phosphorus was significantly increased 
in rats fed the high zinc diet supplemented with phosphorus, 
there was a corresponding increase in the urinary excretion 
of phosphorus which offset the increased apparent absorption 
of this mineral.  This condition actually resulted in a 
decrease in the percentage of phosphorus retained by the 
animal. 
In this study the addition of 0.8% of phosphorus to 
the basal resulted in an improvement in calcium retention. 
In the presence of zinc, however, phosphorus supplementation 
resulted in a negative calcium balance in the animals. 
These results indicate that the levels of dietary calcium 
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and phosphorus used in this study do affect the calcium 
balance of rats under certain conditions.  Whiting and 
Bezeau (27) have reported that the apparent absorption and 
retention of calcium was not influenced by the addition of 
calcium to the diets of pigs.  Miller et al. (28) have 
reported that dietary levels of phosphorus above 0.5% did 
not affect the calcium balance of pigs. 
The effects of calcium and phosphorus supplementa- 
tion, in the absence of zinc toxicity, on the apparent 
absorption and retention of phosphorus in rats under the 
conditions of this study were similar to those observed in 
the pig by Whiting and Bezeau (27) and Miller e_t al. (28). 
The presence of calcium prevented the marked decrease in 
the percentage of phosphorus retained associated with zinc 
toxicity better than did phosphorus supplementation.  Even 
in the absence of zinc, the addition of phosphorus supple- 
ments resulted in greater decreases in the percentage of 
phosphorus retained than did the addition of calcium supple- 
ments. 
Although both calcium and phosphorus supplementation 
improved the apparent absorption and retention of zinc in 
zinc-fed rats, the data indicate that phosphorus has a 
greater influence on zinc metabolism when rats are fed 
toxic levels of zinc.  In the absence of extra zinc, cal- 
cium appeared to have a greater influence on zinc metabolism 
than did phosphorus. 
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The overall results of this investigation indicate 
that the levels of calcium, phosphorus, and zinc in the 
diets of young rats have marked influences on the excretion, 
apparent absorption, and retention of zinc.  Forbes and 
Yohe (29) , however, reported that the apparent absorption 
and urinary excretion of zinc in rats were not influenced 
by additional dietary calcium. 
The results of this study furnish additional support 
for a definite calcium and zinc interrelationship in the 
rat and indicate the existence of a phosphorus and zinc 
interrelationship.  However, the overall results of this 
study suggest a combined interrelationship involving cal- 
cium, phosphorus, and zinc instead of two separate and dis- 
tinct interrelationships.  The data indicate that the 
dietary levels of all three of these minerals have a signi- 
ficant influence on the requirement of any one element, as 
far as the rat is concerned, and that all three minerals 
should be considered when evaluating the dietary adequacy 
of an experimental ration with respect to calcium, phos- 
phorus, and zinc. 
The effect of zinc toxicity on the apparent absorp- 
tion and retention of magnesium was similar to that 
reported by Stewart and Magee (17).  The results also 
indicate that calcium supplements can alleviate the adverse 
effect of zinc toxicity on the retention of magnesium by 
young rats.  The adverse effects of calcium or phosphorus 
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supplements, in the absence of zinc, on the apparent 
absorption of magnesium by the rat were in agreement with 
those observed by Toothill (30).  Presumably, the beneficial 
effect of supplemental calcium on the metabolism of magne- 
sium in zinc-fed rats is to remove excess zinc from the body 
so that it is not present to interfere with the normal 
metabolism of magnesium. 
The results of the copper balance was surprising 
because the adverse effect of zinc toxicity on copper metab- 
olism has been well documented by numerous reports.  The 
results of this study, however, indicate that zinc toxicity 
actually improves the apparent absorption and retention of 
copper.  The retention of copper was increased even more 
when extra phosphorus was added to the high zinc diet. 
The effects of the calcium and phosphorus supplements 
on the weight gains of zinc-fed rats were similar to results 
reported by Stewart and Magee (17).  Addition of an 0.8% 
level of calcium or phosphorus supplement to the diets of 
animals receiving no extra zinc did not result in any 
apparent abnormalities in growth since the mean weight 
gains of the animals receiving the basal supplemented with 
calcium and/or phosphorus were essentially the same as the 
mean weight gain of the control animals. 
The decrease in liver iron level associated with the 
addition of 0.8% calcium to the basal supports the idea 
that a calcium and iron interrelationship exists in the 
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animal body.  Moore et al. (31), however, have emphasized 
that the interrelationship between calcium and iron is 
probably non-specific and is presumably typical of many 
similar interrelationships in mineral metabolism.  Results 
of this study also indicate that phosphorus may have an 
influence on this calcium and iron interrelationship. 
The results of this investigation showing that cal- 
cium and phosphorus supplements could prevent the marked 
accumulation of zinc in the liver paralleled very closely 
the results observed by Stewart and Magee (17) in connection 
with bone zinc levels.  The data of this study also indicate 
that phosphorus has a greater influence on liver zinc 
deposition than does calcium. 
CHAPTER  VI 
SUMMARY  AND   RECOMMENDATIONS 
Summary 
An investigation was conducted to determine the 
effect of high levels of dietary zinc in the presence and 
absence of calcium and phosphorus supplements on the growth 
and the metabolism of calcium, phosphorus, magnesium, copper, 
iron, and zinc in young rats.  Criteria used as measurements 
of the responses of animals maintained on the various dietary 
regimens were the levels of calcium, phosphorus, magnesium, 
copper, and zinc retained by the animals; weight gain; hemo- 
globin level; and liver copper, iron, and zinc levels. 
This study was conducted in two parts.  In the first 
part of the study, a metabolism experiment was conducted to 
determine the effects of high levels of zinc on the apparent 
absorption, the utilization, and the retention of calcium, 
phosphorus, magnesium, copper, and zinc in the presence and 
absence of supplemental levels of calcium and phosphorus. 
The effects of calcium and phosphorus supplements on the 
weight gains; hemoglobin levels; and the deposition of 
copper, iron, and zinc in the livers of zinc-fed rats were 
studied in the second part of the investigation. 
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Results of the study revealed that zinc toxicity 
resulted in highly significant decreases in the retention 
of calcium which could be prevented with calcium supplements. 
Calcium supplementation resulted in marked improvements in 
calcium retention.  Phosphorus supplementation caused an 
increase in calcium retention in the absence of zinc, but 
zinc-fed rats supplemented with added phosphorus were found 
to be in a negative calcium balance. 
Calcium and zinc supplementation resulted in decreases 
in the amount of phosphorus retained, but phosphorus supple- 
mentation was associated with an increase in the total phos- 
phorus retained.  All three supplements, however, were 
associated with decreases in the percentage of phosphorus 
intake that was actually retained.  Calcium supplementation 
resulted in a better percentage of phosphorus retention 
than did supplements of phosphorus. 
The percentage of total magnesium intake retained 
was lower in animals supplemented with calcium, phosphorus, 
and zinc than in animals receiving only the basal diet.  The 
decrease in magnesium retention was associated primarily 
with increases in the amounts of magnesium excreted in the 
feces. 
Zinc toxicity resulted in a highly significant 
increase in the retention and the apparent absorption of 
zinc.  The addition of calcium and phosphorus supplements 
to the high zinc diet resulted in additional increases in 
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zinc retention and the percentage of total zinc intake that 
was retained.  In the absence of zinc, a supplement of 
calcium resulted in a significant increase in the apparent 
absorption of zinc, but the amount absorbed was not suffi- 
cient to overcome the loss of zinc in the urine associated 
with calcium supplementation. 
Although all animals maintained on the various 
dietary regimens used in this study were in negative copper 
balances, the presence of high levels of dietary zinc signif- 
icantly improved copper retention.  In general, calcium 
supplementation improved copper retention, while supplements 
of phosphorus, in the absence of calcium, showed a tendency 
to decrease copper retention.  The improvement in copper 
retention in zinc-fed rats was primarily associated with a 
significant decrease in the fecal excretion of copper. 
Results of this study showed that a high level of 
dietary zinc decreased weight gains, hemoglobin levels, 
liver copper and iron levels and increased liver zinc levels. 
A combination of calcium plus phosphorus supplement par- 
tially alleviated the adverse effect of zinc on weight gain, 
hemoglobin level, and liver copper accumulation.  Supple- 
ments of these two minerals also prevented the marked 
increase in liver zinc deposition associated with zinc 
toxicity. 
The results of this study indicate that an inter- 
relationship between calcium, phosphorus, and zinc exists 
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in the animal body.  Some of the data also indicate that all 
three of these minerals should be considered when evaluating 
the dietary adequacy of an experimental ration with respect 
to calcium, phosphorus, and zinc. 
Recommendations for Additional Investigations 
Results of this study substantiate the proposed 
thesis that an interrelationship exists between phosphorus 
and zinc in the animal body.  The mechanism(s) involving the 
interference of phosphorus metabolism by zinc, however, may 
be more complexed than the one involving the interference 
with calcium metabolism.  Although calcium supplementation 
prevented the decrease in the total percentage of calcium 
retained associated with zinc toxicity, phosphorus supple- 
mentation did not prevent the adverse effect of high levels 
of zinc on the percentage of phosphorus retained by the 
animal.  Additional information is needed to clarify the 
means whereby zinc interferes with phosphorus metabolism. 
The effect of zinc on phosphorus metabolism may be 
mediated through the inactivation or inhibition of some of 
the important energy transferring or transporting enzyme 
systems of the animal body because these systems require 
phosphorus.  Zinc has been shown to interfere with various 
phosphatase enzymes, and there is the possibility that this 
mineral could interfere or inhibit other phosphorus-dependent 
enzymes such as kinases, phosphorylases, or pyrophosphorylases. 
Although the results of this study indicate that 
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zinc interferes primarily with the absorption of magnesium, 
there is the possibility that zinc also interferes with 
enzymes which require magnesium as a cofactor.  Many of the 
enzymes requiring magnesium are involved with energy trans- 
fer and with various stages in the pathways connected with 
the metabolism of carbohydrates, lipids, and proteins.  If 
zinc toxicity results in a magnesium deficiency condition, 
then it is possible that certain enzymes which require 
magnesium for activation would be adversely affected by 
high levels of dietary zinc. 
A decrease in liver zinc accumulation and an increase 
in the apparent absorption and retention of zinc resulted 
when calcium and phosphorus supplements were added to the 
high zinc diet.  These findings prompt the intriguing ques- 
tion of where is the excess zinc accumulating in the animal 
body under the experimental conditions of this study. 
There is the possibility that zinc is accumulating in other 
organs of the body.  Additional studies are needed to deter- 
mine the exact fate of the excess zinc which is present 
under the conditions utilized in this study. 
Previous results have indicated that zinc interferes 
with copper metabolism.  Results of this study, however, 
indicate that although zinc may interfere with certain 
phases of copper metabolism it may also improve the apparent 
absorption and retention of copper.  Additional studies are 
needed to clarify these supposedly contradictory findings. 
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TABLE 1 
MINERAL ANALYSES OF DIETS USED IN THE STUDY 
1 -  Control 
2 -  0.8% Ca 
3 -  0.8%  P 
4 -  0.8% Ca  +  0.8%  P 
Diets 
5 -  0.75% Zn 
6 -  0.7 5% Zn  +  0.8% Ca 
7 -  0.75% Zn +  0.8%  P 
8 -  0.75% Zn +  0.8% Ca  +  0.8%  P 
Diets                  Zna Caa Pa              •     Mgb                 Cub 
0.003 
0.008 
0.004 
0.004 
4.447 
6.200 
5.554 
3.834 
5.12 
20.32 
6.26 
20.00 
6.04 
17.09 
6.48 
16.20 
5.46 
5.30 
13.46 
13.06 
5.99 
5.66 
14.61 
13.08 
0.52 
0.52 
0.53 
0.55 
0.61 
0.63 
0.58 
0.56 
5.83 
5.00 
4.67 
4.91 
4.50 
4.34 
5.11 
4.37 
aExpressed as mg./gm. of diet on a fresh weight 
basis. 
basis. 
^Expressed as mcg./gm. o f diet on a fresh weight 
TABLE 2 
CALCIUM BALANCE DATA 
Rep. 
Supplement (per cent added to diet) 
Item Ca 0 
P  0 
Zn 0 
0.8 
0 
0 
0 
0.8 
0 
0.8 
0.8 
0 
0 
0 
0.75 
0.8 
0 
0.75 
0 
0.8 
0.75 
0.8 
0.8 
0.75 
Total amount per co! Llection period (mg • ) 
Ca intake 1 
2 
3 
4 
373.76 
506.88 
501.76 
491.52 
2072.64 
2113.28 
2052.32 
1828.80 
619.74 
494.54 
594.70 
1588.44 
2040.00 
2040.00 
2040.00 
2060.00 
462.77 
516.86 
354.59 
384.64 
1623.55 
1760.27 
1230.48 
1213.39 
492.48 
615.60 
473.04 
641.52 
1458.00 
1668.60 
1684.80 
1701.00 
Total 1873.82 8067.04 2297.42 8180.00 1718.86 5827.69 2222.64 6512.40 
Mean 468.46 2016.76 574.36 2045.00 429.72 1456.92 555.66 1628.10 
Fecal Ca 1 
2 
3 
4 
239.11 
250.50 
293.48 
308.63 
892.17 
925.66 
762.63 
1381.32 
269.66 
196.48 
258.29 
266.76 
435.19 
797.60 
617.46 
658.96 
426.25 
396.99 
316.24 
407.48 
986.83 
1181.37 
791.82 
489.43 
435.19 
528.66 
311.70 
1204.84 
1000.15 
636.56 
1170.51 
866.64 
Total 1091.72 3961.78 991.19 2509.21 1546.96 3449.45 2480.39 3673.86 
Mean 272.93 990.45 247.80 627.30 386.74 862.36 620.10 918.47 
to 
TABLE 2—Continued 
Rep. 
Supplement (per cent added to diet) 
Item Ca 0 
P  0 
Zn 0 
0.8 
0 
0 
0 
0.8 
0 
0.8 
0.8 
0 
0 
0 
0.75 
0.8 
0 
0.75 
0 
0.8 
0.75 
0.8 
0.8 
0.75 
Urinary Ca 1 
2 
3 
4 
1.27 
4.53 
2.78 
5.62 
3.26 
15.28 
4.43 
9.31 
11.58 
6.67 
7.14 
19.59 
15.51 
4.06 
13.45 
23.97 
2.61 
3.74 
1.20 
14.38 
0.95 
2.03 
1.49 
7.50 
6.40 
11.08 
8.02 
32.03 
4.04 
7.24 
4.51 
16.75 
Total 14.20 32.28 44.98 56.99 21.93 11.97 57.53 32.54 
Mean 3.55 8.07 11.25 14.25 5.48 2.99 14.38 8.14 
Ca retention 
1 
2 
3 
4 
133.38 
251.85 
205.50 
177.27 
1177.21 
1172.34 
1285.26 
438.17 
338.50 
291.39 
329.27 
302.09 
1589.30 
1238.34 
1409.09 
1377.07 
33.91 
116.13 
37.15 
-37.22 
635.77 
576.87 
437.17 
716.46 
50.89 
75.86 
153.32 
-396.35 
453.81 
1024.80 
509.78 
817.61 
Total 768.00 4072.98 1261.25 5613.80 149.97 2366.27 -316.28 2806.00 
Mean 192.00 1018.25 315.31 1403.15 37.49 591.57 - 79.09 701.50 
TABLE 3 
PHOSPHORUS BALANCE DATA 
Supplement (per cent added to diet) 
Item    Rep. Ca 0 
P  0 
Zn 0 
0.8 
0 
0 
0 
0.8 
0 
0.8 
0.8 
0 
0 
0 
0.75 
0.8 
0 
0.75 
0 
0.8 
0.75 
0.8 
0.8 
0.75 
Total amount per co llection period (rag .) 
P intake 1 
2 
3 
4 
398.58 
540.54 
535.08 
524.16 
540.60 
551.20 
535.30 
447.10 
1332.54 
1063.34 
1278.70 
1265.24 
1332.12 
1332.21 
1332.12 
1345.18 
461.23 
515.40 
353.41 
383.36 
537.70 
582.98 
407.52 
560.34 
1110.36 
1387.95 
1066.53 
1037.31 
1177.20 
1347.24 
1360.32 
1373.40 
Total 1998.36 2074.10 4939.82 5341.54 1713.40 2088.54 4602.15 5258.16 
Mean 499.59 518.53 1234.96 1335.38 428.35 522.14 1150.14 1314.54 
Fecal P 1 
2 
3 
4 
97.95 
77.56 
94.42 
122.70 
320.00 
267.98 
328.66 
298.77 
160.78 
106.87 
131.31 
218.61 
291.56 
380.13 
272.80 
494.22 
255.15 
288.84 
182.75 
251.54 
333.31 
419.95 
231.00 
274.44 
344.00 
339.29 
201.50 
444.77 
331.84 
578.31 
526.60 
602.95 
Total 392.53 1206.41 617.57 1438.71 918.28 1258.70 1329.56 2039.70 
Mean 98.16 301.60 154.39 359.68 229.57 314.68 332.39 509.93 
*> 
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TABLE 3—Continued 
i. 
Supplement (per cent added to diet) 
Item    Rep Ca 0 0.8 0 0.8 0 0.8 0 0.8 
P  0 0 0.8 0.8 0 0 0.8 0.8 
Zn 0 0 0 0 0.75 0.75 0.75 0.75 
Urinary P 1 11.76 14.08 487.45 662.53 62.77 18.05 584.26 331.97 
2 182.17 45.89 634.27 355.16 83.71 140.20 984.36 501.56 
3 228.01 11.38 719.25 464.89 68.19 20.25 444.57 482.14 
4 178.60 6.14 861.47 579.25 250.50 99.14 380.45 398.90 
Total 600.54 77.49 2702.44 2061.83 465.17 277.64 2393.64 1714.57 
Mean 150.14 19.37 675.61 515.47 116.29 69.41 598.41 428.64 
P retention 
1 288.87 206.52 684.31 378.03 143.31 186.34 182.10 513.39 
2 280.81 237.33 322.20 596.83 202.85 22.83 64.30 267.37 
3 212.65 195.26 428.14 594.43 102.47 156.27 420.46 351.58 
4 222.80 181.09 185.16 271.71 -118.68 186.76 212.09 371.55 
Total 1005.13 820.20 1619.81 1841.00 329.95 552.20 878.95 1503.89 
Mean 251.28 205.05 404.95 460.25 82.49 138.05 219.74 375.97 
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TABLE 4 
MAGNESIUM BALANCE DATA 
). 
Supplement (per cent added to diet) 
Item    Rej Ca 0 
P 0 
Zn 0 
0.8 
0 
0 
0 
0.8 
0 
0.8 
0.8 
0 
0 
0 
0.75 
0.8 
0 
0.75 
0 
0.8 
0.75 
0.8 
0.8 
0.75 
Total amount per co llection period (mctj .) 
Mg intake 1 
2 
3 
4 
40.04 
51.48 
50.96 
49.92 
53.04 
54.08 
52.52 
46.80 
52.47 
41.87 
50.35 
49.82 
56.10 
56.10 
56.10 
56.65 
46.97 
52.46 
35.99 
39.04 
59.85 
65.92 
46.08 
60.36 
44.08 
55.10 
42.43 
41.18 
50.40 
57.68 
58.24 
58.80 
Total 192.40 206.44 194.51 224.95 174.46 232.21 182.70 225.12 
Mean 48.10 51.61 48.63 56.24 43.62 58.05 45.68 56.28 
Fecal Mg 1 
2 
3 
4 
11.81 
10.38 
14.80 
17.84 
26.43 
23.98 
30.62 
33.14 
23.02 
19.81 
21.61 
24.17 
22.53 
28.39 
16.29 
35.19 
20.83 
21.64 
12.81 
21.29 
30.60 
30.87 
16.82 
17.10 
22.83 
35.19 
15.38 
32.61 
26.76 
38.13 
34.66 
21.33 
Total 54.83 114.17 88.61 102.40 76.57 95.39 106.01 120.88 
Mean 13.71 28.54 22.15 25.60 19.14 23.85 26.50 30.22 
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TABLE 4—Continued 
>. 
Supplement (per cent added to diet) 
Item     Rej Ca 0 0.8 0 0.8 0 0.8 0 0.8 
P  0 0 0.8 0.8 0 0 0.8 0.8 
Zn 0 0 0 0.75 0.75 0.75 0.75 0.75 
Urinary Mg 1 1.45 0.59 0.64 0.59 0.67 0.18 0.99 0.72 
2 0.75 1.71 0.90 0.53 0.65 0.18 1.68 0.97 
3 0.73 0.74 0.72 1.73 1.09 0.14 1.41 0.57 
4 2.53 0.88 3.67 0.31 2.92 9.78 1.03 0.88 
Total 5.46 3.92 5.93 3.16 5.33 10.28 5.11 3.14 
Mean 1.36 0.98 1.48 0.79 1.33 2.57 1.28 0.79 
Mq retention 
1 26.78 26.02 28.81 32.98 25.47 29.07 20.26 22.92 
2 40.35 28.39 21.16 27.18 30.17 34.87 18.23 18.58 
3 35.43 21.16 28.02 38.08 32.09 29.12 25.55 23.01 
4 29.55 12.78 21.98 21.15 14.83 33.39 7.54 36.59 
Total 132.11 88.35 99.97 119.39 102.56 126.45 71.58 101.10 
Mean 33.03 22.09 24.99 29.85 25.64 31.61 17.90 25.28 
TABLE 5 
ZINC BALANCE DATA 
>. 
Supplement (per cent added to diet) 
Item     Rep Ca 0 0.8 0 0.8 0 0.8 0 0.8 
P  0 0 0.8 0.8 0 0 0.8 0.8 
Zn 0 0 0 0 0.75 0.75 0.75 0.75 
Total amount per cc illection period (mg .) 
Zn intake 1 0.219 0.816 0.396 0.408 342.419 589.000 422.104 345.060 
2 0.297 0.832 0.316 0.408 382.442 638.600 527.630 394.902 
3 0.294 0.808 0.380 0.408 262.373 446.400 405.422 398.736 
4 0.288 0.720 0.376 0.412 284.608 613.800 394.334 402.570 
Total 1.098 3.176 1.468 1.636 1271.842 2287.800 1749.510 1541.268 
Mean 0.275 0.794 0.367 0.409 317.961 571.950 437.378 385.317 
Fecal Zn 1 0.306 0.612 0.329 0.555 227.753 289.995 131.149 147.329 
2 0.277 0.318 0.258 0.312 174.044 356.042 35.898 151.278 
3 0.582 0.487 0.352 0.720 46.900 54.488 113.265 136.019 
4 18.723 0.472 6.517 7.311 156.815 350.673 114.351 86.093 
Total 19.888 1.889 7.456 8.898 605.512 1051.198 394.663 520.719 
Mean 4.972 0.472 1.864 2.225 151.378 268.800 98.666 130.180 
03 
TABLE 5—Continued 
>. 
Supplement (per cent added to diet) 
Item     Rej Ca 0 
P 0 
Zn 0 
0.8 
0 
0 
0 
0.8 
0 
0.8 
0.8 
0 
0 
0 
0.75 
0.8 
0 
0.75 
0 
0.8 
0.75 
0.8 
0.8 
0.75 
Urinary Zn 1 
2 
3 
4 
0.034 
0.227 
0.045 
0.498 
0.024 
0.321 
0.182 
2.228 
0.090 
0.129 
0.156 
1.050 
0.008 
0.084 
0.237 
0.709 
0.340 
0.606 
0.452 
2.068 
0.908 
0.325 
0.230 
3.787 
0.217 
0.594 
0.192 
1.623 
0.148 
0.211 
0.788 
0.702 
Total 0.804 2.807 1.425 1.038 3.446 5.250 2.626 1.844 
Mean 0.201 0.702 0.356 0.259 0.862 1.312 0.657 0.462 
Zn 1 
2 
3 
4 
- 0.121 
- 0.157 
- 0.333 
-18.933 
0.180 
-0.193 
0.139 
-2.032 
-0.023 
-0.071 
-0.128 
-7.191 
-0.155 
0.012 
-0.545 
-7.608 
114.326 
207.792 
215.021 
125.745 
298.097 
282.233 
391.682 
259.340 
290.738 
491.138 
291.985 
278.360 
197.583 
243.413 
261.929 
315.776 
Total -19.544 -1.520 -7.413 -8.296 662.884 1231.352 1352.221 1018.701 
Mean - 4.886 -0.380 -1.853 -2.074 165.721 307.838 338.055 254.675 
TABLE   6 
COPPER  BALANCE   DATA 
. 
Supplement (per cent added to diet) 
Item    Rep Ca 0 
P 0 
Zn 0 
0.8 
0 
0 
0 
0.8 
0 
0.8 
0.8 
0 
0 
0 
0.75 
0.8 
0 
0.75 
0 
0.8 
0.75 
0.8 
0.8 
0.75 
Total amount per collection period (meg.) 
Cu intake 1 
2 
3 
4 
425.59 
577.17 
571.34 
559.68 
510.00 
520.00 
505.00 
450.00 
462.33 
368.93 
443.65 
438.98 
500.82 
500.82 
500.82 
505.73 
346.50 
387.00 
265.50 
288.00 
412.30 
447.02 
312.48 
429.66 
388.36 
485.45 
373.03 
362.81 
393.30 
450.11 
454.48 
458.85 
Total 2133.78 1985.00 1713.89 2008.19 1287.00 1601.46 1609.65 1756.74 
Mean 533.45 496.25 428.47 502.05 321.75 400.37 402.41 439.19 
Fecal Cu 1 
2 
3 
4 
2551.99 
3149.96 
3186.87 
3969.48 
5226.61 
3422.11 
485.04 
3090.79 
3466.04 
2775.10 
3751.10 
3483.06 
3074.81 
2857.93 
186.26 
1812.62 
1398.10 
363.63 
353.42 
368.78 
622.16 
586.99 
363.14 
652.07 
513.10 
478.45 
356.01 
344.67 
749.76 
499.89 
725.13 
543.07 
Total 12858.30 12224.55 13475.30 7931.62 2483.93 2224.36 1692.23 2517.85 
Mean 3214.58 3056.14 3368.83 1982.91 620.98 556.09 423.06 629.46 
o 
TABLE 6—Continued 
>. 
Supplement (per cent added to diet) 
Item    Re i Ca 0 
P 0 
Zn 0 
0.8 
0 
0 
0 
0.8 
0 
0.8 
0.8 
0 
0 
0 
0.75 
0.8 
0 
0.75 
0 
0.8 
0.75 
0.8 
0.8 
0.75 
Urinary Cu 1 
2 
3 
4 
7.11 
8.29 
8.57 
12.92 
25.19 
83.79 
11.10 
28.12 
45.92 
103.43 
14.69 
11.99 
43.59 
12.00 
11.32 
25.65 
3.04 
2.53 
16.78 
20.83 
11.95 
9.76 
21.62 
2.10 
4.10 
10.68 
10.35 
29.00 
4.35 
26.04 
24.75 
Total 36.89 148.20 179.03 92.56 43.18 43.33 27.23 84.14 
Mean 9.22 37.05 44.76 23.14 10.79 14.44 6.81 21.04 
Cu 
retention 
1 
2 
3 
4 
-2133.51 
-2581.08 
-2624.10 
-3422.72 
-4741.80 
-2985.90 
8.86 
-2668.91 
-3049.63 
-2509.60 
-3322.14 
-3059.07 
-2617.58 
-2369.11 
- 303.24 
-1332.54 
-1054.64 
20.84 
- 104.70 
- 101.61 
-221.81 
-139.97 
- 60.42 
-244.03 
-126.83 
2.90 
6.34 
7.79 
-385.46 
- 54.13 
-296.69 
-108.97 
Total -10761.41 
-10387.75 
-11940.44 
-6015.99 
-1240.11 
-666.23 
-109.80 
-845.25 
Mean -2690.35 -2596.94 -2974.11 -1504.00 - 310.63 -166.56 - 27.45 -211.31 
Ul 
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TABLE 1 
GROWTH DATA 
1 - Control 
2 - 0-8% Ca 
3 - 0.8% P 
4 - 0.8% Ca + 0, 
Treatments 
5 - 0.75% Zn 
6 - 0.75% Zn + 0.8% Ca 
7 - 0.75% Zn + 0.8% P 
8 - 0.75% Zn + 0.8% Ca + 0.8% P 
Rep. 
Treatments 
3      4      5 
4 weeks weight gain (gm ) 
1 115 115 197 197 157 165 156 146 
2 207 205 151 178 173 201 162 171 
3 191 204 200 186 109 131 112 177 
4 174 124 159 184 124 170 115 178 
5 163 174 139 154 126 117 98 115 
6 162 168 161 147 120 116 96 146 
7 163 160 143 156 118 120 92 122 
8 173 183 161 98 80 80 70 138 
Total   1348   1333   1311   1300   1007   1100   900   1193 
164    162    126    138   112    149 Mean 169 167 
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TABLE 2 
HEMOGLOBIN DATA 
1 - Control 
2 - 0.8% Ca 
3 - 0.8% P 
4 - 0.8% Ca + 0.8% P 
Treatments 
5 - 0.75% Zn 
6 - 0.75% Zn 
7 - 0.75% Zn 
8 - 0.75% Zn 
+ 0.8% Ca 
+ 0.8% P 
+ 0.8% Ca + 0.8% P 
Rep.    1       2 
Treatments 
3       4      5 6     7     8 
mg./lOO ml. blood 
14.55  7.77 7.37 9.83 11.14 
13.95  6.80 7.37 9.29 14.23 
13.29  8.54 6.23 8.00 12.09 
14.55  8.43 8.54 7.14 11.92 
12.69  5.74 7.48 8.18  9.29 
12.34  5.06 9.72 7.42  8.60 
13.03  6.08 6.92 7.09  8.66 
12.26  7.65 7.20 5.54 10.26 
Total  106.90  103.45  107.44  106.66 56.07 60.83 62.49 86.19 
Mean    13.40   12.93   13.43   13.33  7.01 7.60 7.81 10.77 
1 12.86 13.66 14.43 
2 13.66 14.43 11.37 
3 14.35 13.66 14.86 
4 14.86 13.03 15.57 
5 13.29 13.12 13.40 
6 12.34 12.00 12.60 
7 12.77 12.09 12.69 
8 12.77 11.46 12.52 
55 
TABLE 3 
LIVER COPPER DATA 
Treatmeni ts 
1 _ Control 5 -  0 .75% Zn 
2 - 0 .8% Ca 6 -  0 .75% Zn + 0 .8% Ca 
3 - 0 .8% P 7 -  0 75% Zn + 0 .8% Ca + 0 .8% P 
4 — 0 .8% Ca + 0 .8% P 8 -  0 75% Zn + 0 .8% Ca + 0 .8% P 
Rep. 
Treatments 
3 4 5 
mcg./gm.   dry weight 
1 9.51 13.57 17.09 13.90 5.18 
2 14.73 2.82 18.44 14.40 3.89 
3 5.85 11.86 3.20 12.00 5.03 
4 6.09 13.68 1.42 13.93 6.54 
5 12.68 - 15.87 10.46 2.14 
6 8.96 20.59 12.04 11.13 2.02 
7 11.93 11.54 10.73        8.74 1.75 
8 11.66 11.66 12.24 15.27 2.20 
6.34 6.57 4.70 
3.82 3.20 11.26 
6.10 4.38 10.43 
3.27 3.59 8.88 
1.25 1.05 2.59 
4.14 2.43 2.91 
1.12 0.48 2.30 
2.44 0.65 7.29 
Total     84.41     85.82     91.03     99.83     28.75     28.48     22.35     50.36 
Mean        10.18     12.26     11.38     12.48        3.59       3.56       2.79       6.30 
TABLE 4 
LIVER IRON DATA 
Treatments 
1 - Control 5 - 0.75% Zn 
2-0. 8% Ca 6 - 0.75% Zn + 0.8% Ca 
3-0. 8% P 7 - 0.75% Zn + 0.8% P 
4-0. 8% Ca + 0. 8% P 8 - 0.75% Zn + 0.8% Ca + 0.8% P 
Treatments 
Rep. 1 2 3 4 5 6 7 8 
meg./gm . dry weight 
1 216.20 209.34 234.83 218.31 85.67 126.99 111.96 150.62 
2 314.85 331.45 280.98 175.43 141.31 110.06 100.18 173.67 
3 283.45 346.35 268.34 256.06 146.30 165.40 123.57 203.52 
4 269.47 287.10 219.98 167.68 117.37 98.10 147.46 179.90 
5 289.41 178.74 362.63 235.54 152.93 112.41 109.04 102.49 
6 216.96 208.26 310.29 244.07 90.70 103.25 96.71 146.93 
7 323.97 324.38 276.35 198.24 106.61 139.22 97.34 131.52 
8 294.57 148.20 211.81 165.03 120.96 108.61 110.28 117.60 
Total 2208.88 2033.82 2165.21 1660.36 961.85 964.03 896.54 1206.25 
Mean 176.91 254.23 270.65 207.55 120.23 120.50 112.07 150.78 en 
TABLE 5 
LIVER ZINC DATA 
Treatments 
1 
2 
3 
4 
Control 
0.8% Ca 
0.8% P 
0.8% Ca + 0.8% P 
5 - 0.75% Zn 
6 - 0.75% Zn + 0.8% Ca 
7 - 0.75% Zn + 0.8% P 
8 - 0.75% Zn + 0.8% Ca + 0.8% P 
Treatments 
Rep. 1 2 3 4 5 6 7 8 
meg ./gm. dry weight 
1 21.4 24.9 26.9 36.5 265.3 227.1 137.3 131.2 
2 19.7 25.3 21.1 31.5 300.0 91.5 92.6 69.9 
3 23.0 53.1 28.5 43.9 - 127.9 81.1 82.4 
4 - 18.2 39.8 22.8 172.0 84.2 98.5 75.4 
5 47.5 34.4 53.1 77.5 409.0 350.0 217.1 99.5 
6 53.2 49.6 83.4 83.4 436.2 373.1 330.6 41.3 
7 44.8 25.5 51.7 56.7 433.1 263.6 258.1 102.9 
8 37.6 24.6 31.1 53.6 429.6 416.4 291.0 111.3 
Total 247.2 256.4 355.7 405.9 2445.2 1934.2 1506.4 713.9 
Mean 35.3 32.1 42.0 50.7 349.3 241.8 189.3 89.2 
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TABLE   1 
ANALYSES   OF  VARIANCE  OF   RETENTION   DATA 
FOR   EACH  MINERAL   STUDIED 
Source of Degrees of Sum of Mean 
Variation Freedom Squares Square 
Calcium 
Total 31 8 ,390,759.67 
Replications 3 172,644.14 57,548.05 
Treatments 7 7 ,231,592.14 1,033,084.59** 
Zn 1 1,407,032.48 1,407,032.48** 
Ca 1 5,278,089.85 5,278,089.85** 
P 1 125,945.53 125,945.53** 
ZnCa 1 168,047.78 168,047.78** 
ZnP 1 132,688.47 132,688.47** 
CaP 1 119,261.18 119,261.18** 
ZnCaP 1 626.49 626.49 
Error 21 172,644.14 8,221.15 
Phosphorus 
Total 31 894,558.19 
Replications 3 89,283.49 29,761.16 
Treatments 7 500,970.66 71,567.24** 
Zn 1 127,657.73 127,657.73** 
Ca 1 24,390.12 24,390.12 
p 1 307,361.32 307,361.32** 
ZnCa 1 20,550.23 20,550.23 
ZnP 1 567.76 567.76 
CaP 1 20,442.92 20,442.92 
ZnCaP 
Error 21 
1 0.37 
304,304.04 
0.37 
14,490.67 
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TABLE   l--Continued 
Source  of 
Variation 
Degrees   of 
Freedom 
Sum of 
Squares 
Mean 
Square 
Total 31 
Replications 3 
Treatments 7 
Zn   . 1 
Ca 1 
P 1 
ZnCa 1 
ZnP 1 
CaP 1 
ZnCaP 1 
Error 21 
Magnesium 
1,713.10 
157.26 
744.91 
74.24 
47.82 
70.15 
240.35 
64.07 
107.90 
142.38 
810.93 
52.42 
106.42* 
74.24 
47.82 
70.15 
240.35* 
64.07 
107.90 
142.38 
38.61 
Zinc 
Total 31 
Replications 3 
Treatments 7 
Zn 1 
Ca 1 
P 1 
ZnCa 1 
ZnP 1 
CaP 1 
ZnCaP 1 
Error 21 
703,249.34 
9,497.09 
646,874.84 
578,331.57 
1,985.90 
7,261.36 
1,482.50 
6,942.28 
26,501.49 
24,369.75 
48,877.41 
3,165.70 
92,410.69** 
578,331.57** 
1,985.90 
7,261.36 
1,482.50 
6,942.28 
26,501.49** 
24,369.75** 
2,232.26 
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TABLE   1—Continued 
Source  of 
Variation 
Degrees   of 
Freedom 
Sum  of 
Squares 
Mean 
Square 
Total 31 
Replications 3 
Treatments 7 
Zn 1 
Ca 1 
P 1 
ZnCa 1 
ZnP 1 
CaP 1 
ZnCaP 1 
Error 21 
Copper 
65.38 
4.27 
46.89 
41.10 
1.17 
0.54 
1.30 
0.16 
0.56 
1.48 
14.22 
1.42 
6.73** 
41.10** 
1.17 
0.54 
1.30 
0.16 
0.56 
1.48 
0.68 
*Significant   (p-^.0.05). 
** Highly  significant   (p^O.01). 
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TABLE   2 
ANALYSES   OF   VARIANCE   OF  FECAL  EXCRETION  DATA 
Source  of Degrees   of Sum of Mean 
Variation Freedom Squares Square 
Calcium 
Total 31 3,586,241.37 
Replications 3 81,825.04 27,275.01 
Treatments 7 2,389,851.89 369,617.30** 
Zn 1 210,723.83 210,723.83 
Ca 1 1,750,339.21 1,750,339.21** 
P 1 4,882.20 4,882.20 
ZnCa 1 52,174.19 52,174.19 
ZnP 1 229,662.37 229,662.37* 
CaP 1 132,749.01 132,749.01 
ZnCaP 1 12,921.09 12,921.09 
Error 21 1,114,564.44 53,074.50 
Phosphorus 
Total 31 597,686.48 
Replications 3 37,956.43 12,655.14 
Treatments 7 458,234.10 65,462.01** 
Zn 1 111,738.01 111,738.01** 
Ca 1 225,370.52 225,370.52** 
p I 85,029.66 
85,029.66** 
ZnCa 10,671.51 10,671.51 
ZnP 1 16,929.38 16,929.38 
CaP 1 4,443.18 4,443.18 
ZnCaP 1 4,103.50 4,103.50 
Error 21 101,487.01 4,832.71 
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TABLE   2—Continued 
Source  of Degrees   of Sum of Mean 
Variation Freedom Squares Square 
Magnesium 
Total 31 1,575.25 
Replications 3 156.86 52.29 
Treatments 7 801.83 114.55* 
Zn 1 47.14 47.14 
Ca 1 356.58 356.58** 
P 1 184.99 184.99* 
ZnCa 1 48.61 48.61 
ZnP 1 33.87 33.87 
CaP 1 76.57 76.57 
ZnCaP 1 54.08 54.08 
Error 21 758.58 36.12 
Zinc 
Total 31 348,189.31 
Replications 3 15,395.17 5 ,131.72 
Treatments 7 261,395.17 37 ,408.75** 
Zn 1 200,654.99 200 ,654.99** 
Ca 1 9,632.20 9 632.20 
p 1 17,425.74 17 ,425.74* 
ZnCa 1 10,815.49 10 ,815.49 
ZnP { 
16,923.63 16 ,923.63* 
CaP 2,816.04 2 816.04 
ZnCaP 1 3,592.90 3 
,592.90 
Error 21 70,932.89 3 
,377.76 
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TABLE 2—Continued 
Source of Degrees  of Sum of Mean 
Variation Freedom Squares Square 
Copper 
Total 31 66.92 
Replications 3 3.73 1.24 
Treatments 7 49.37 7.05** 
Zn 1 45.42 45.42** 
Ca 1 0.83 0.83 
p 1 0.43 0.43 
ZnCa 1 1.20 1.20* 
ZnP 0.22 0.22 
CaP 1 0.36 0.36 
ZnCaP 1 0.93 0.93* 
Error 21 3.73 0.18 
*Signif icant (p «g*Q - 05) . 
**Highly significant (p^O.Ol). 
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TABLE 3 
ANALYSES OF VARIANCE OF WEIGHT GAIN, HEMOGLOBIN, 
LIVER COPPER, LIVER IRON, AND LIVER ZINC DATA 
Source  of Degrees  of Sum of Mean 
Variation Freedom Squares Square 
Weight  gain 
Total 63 95,542.75 
Replications 7 19,835.75 2,833.65 
Treatments 7 24,719.25 3,531.32** 
Zn 1 18,632 .25 18,632.25** 
Ca 1 2,025 25 2,025.25 
P 1 110 25 110.25 
ZnCa 1 2,652 25 2,652.25 
ZnP 1 49 00 49.00 
CaP 1 650 00 650.00 
ZnCaP 1 600 25 600.25 
Error 49 30,987.75 632.40 
Hemoglobin 
Total 63 555.17 
Replications 7 34.30 4.90 
Treatments 7 463.67 66.24** 
Zn 1 394 37 394.37** 
Ca 1 9 17 9.17** 
P 
ZnCa 
ZnP 
1 19. 72 19.72** 
1 
1 
16. 
12. 
70 
28 
16.70** 
12.28** 
CaP 
ZnCaP 
1 
1 
7. 
4. 
30 
14 
7.30 
4.14 
1.17 
Error 49 57.19 
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TABLE   3—Continued 
Source  of Degrees of                  Sum of Mean 
Variation Freedom Squares Squares 
Liver  copper 
Total 62 1, 647 . 90 
Replications 7 71.01 10.14 
Treatments 7 969.01 138.43** 
Zn 1 891.10 891.10** 
Ca 1 41.59 41.59 
P 1 3.11 3.11 
ZnCa 1 12.66 12.66 
ZnP 1 0.25 0.25 
CaP I 1.69 1.69 ZnCaP 18.61 18.61 
Error 48 607.88 12.66 
Liver  iron 
Total 63 382,652.69 
Replications 7 2,312.36 330.34 
Treatments 7 285,230.25 40,747.18** 
Zn 1 254,974.50 254,974.50** 
Ca 1 2,116.23 2,116.23 
p 1 901.65 901.65 
ZnCa 1 15,369.80 15,369.80** 
ZnP 1 5,513.81 5,513.81 
CaP 1 7.74 7.74 
ZnCaP 1 6,346.51 
6,346.51 
Error 49 95,110.08 1,941.02 
TABLE 3—Continued 
*Significant (p^0.05) 
**Highly significant (p^.0.01) 
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Source of Degrees  of Sum of Mean 
Variation Freedom Squares Square 
Liver  zinc 
Total 63 1,017,473.37 
Replications 7 143,876.49 20,553.78 
Treatments 7 666,073.04 95,153.29** 
Zn 454,141 21 454,141.21** 
Ca 23,893 43 23,893.43** 
p 60,417 64 60,417.64** 
ZnCa 32,492 25 32,492.25** 
ZnP 95,552 85 95,552.85** 
CaP 304 50 304.50 
ZnCaP 1,821 .15 1,821.15 
Error 49 207,523.84 4,235.18 
